$ACT Company News

New Post Public Reply Private Reply Replies (0) Message Board

May 15, 2014 at 11:51 AM

$ACT Company News

Pfizer's plan to relocate after merger deal draws lawmakers' fire

11:30 a.m. May 9, 2014
- blogs.marketwatch.com

Corner drug store may move overseas to save on taxes
6:30 a.m. April 16, 2014
- Al Lewis

Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Saumya Vaishampayan

Actavis acquires Silom Medical for $100 million
10:19 a.m. April 1, 2014
- MarketWatch.com

The 10 most overbought stocks in the S&P 500 index
12:19 p.m. March 25, 2014
- The Trading Deck

UK drug rejection, patent concerns take a bite out of Celgene shares

1:33 p.m. March 14, 2014
- blogs.marketwatch.com

Mylan to start selling generic Celebrex in May
7:22 a.m. March 13, 2014
- MarketWatch.com

Pfizer loses Celebrex patent ruling; shares halted but effect muted

3:21 p.m. March 12, 2014
- blogs.marketwatch.com

Staples awash in red; eBay up as Icahn posts new letter
4:09 p.m. March 6, 2014
- Victor Reklaitis

Icahn Enterprises reports profit up 144% in 2013
10:22 a.m. March 3, 2014
- MarketWatch

Citadel hedge fund’s recent moves
11:12 a.m. Feb. 25, 2014
- Insider Monkey

Stocks rally; S&P 500 ends right below record
4:45 p.m. Feb. 24, 2014
- Victor Reklaitis

U.S. stock market is starting to ride a tech M&A wave
5:31 a.m. Feb. 24, 2014
- Wallace Witkowski

Actavis continues hot streak with better-than-expected earnings

11:21 a.m. Feb. 20, 2014
- blogs.marketwatch.com

Actavis swings to loss on charges, write-downs
8:03 a.m. Feb. 20, 2014
- MarketWatch.com

Pharma megamergers bring higher profits, better returns, study says

1:59 p.m. Feb. 19, 2014
- blogs.marketwatch.com

Actavis, Forest shares continue their climb in aftermath of $25 billion deal

11:03 a.m. Feb. 19, 2014
- blogs.marketwatch.com

U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova

Forest Laboratories, Actavis surge on buyout deal
4:10 p.m. Feb. 18, 2014
- Ben Eisen

S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap

4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com

Actavis extends marketing agreement

9:32 a.m. Today9:32 a.m. May 15, 2014
- Seeking Alpha

Lilly loses Alimta patent case in U.K. to Actavis

8:56 a.m. Today8:56 a.m. May 15, 2014
- Seeking Alpha

Lilly Says Court Rules in Favor of Generic Maker on Alimta

6:44 a.m. Today6:44 a.m. May 15, 2014
- The Wall Street Journal Interactive Edition

New leadership team at Actavis after Forest deal closes

9:56 a.m. May 14, 2014
- Seeking Alpha

Forest Labs' Saunders to Head Actavis When Deal Closes

8:55 a.m. May 14, 2014
- The Wall Street Journal Interactive Edition

Cross-Border Megamergers Drive Global Takeover Boom

4:01 p.m. May 12, 2014
- Investors Business Daily

3 Drugs Stocks On The Rise

1:02 p.m. May 12, 2014
- TheStreet.com

Actavis and Valeant settle patent fight

8:26 a.m. May 12, 2014
- Seeking Alpha

The 'Inversion' Premium

7:29 p.m. May 11, 2014
- The Wall Street Journal Interactive Edition

Vivus Discloses Competitive Threat

10:51 a.m. May 10, 2014
- Seeking Alpha

M.D. Sass: Bullish on Broadcast, Health Care

3:26 a.m. May 10, 2014
- Barrons.com

Acorda Misses on Earnings, Beats Revs - Analyst Blog

1:43 p.m. May 7, 2014
- Zacks.com

3 Drugs Stocks Dragging The Industry Down

1:03 p.m. May 7, 2014
- TheStreet.com

What Does Celgene's May 15 Markman Hearing Mean to You?

10:11 a.m. May 7, 2014
- TheStreet.com

Actavis, Michael Kors Among World Stocks Near Buy Points

5:50 p.m. May 6, 2014
- Investors Business Daily

10-Q: ACTAVIS PLC
5:15 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)

Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV

1:45 p.m. May 5, 2014
- InvestorPlace.com

Best Five Stocks Over $100
10:07 a.m. May 3, 2014
- 247WallSt.com

AstraZeneca Nixes New Bid As Pfizer Woos British PM

1:11 p.m. May 2, 2014
- Investors Business Daily

Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog

12:10 p.m. May 2, 2014
- Zacks.com

Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta®
8:45 a.m. Today8:45 a.m. May 15, 2014
- PR Newswire - PRF

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Forest Laboratories Acquisition
8:00 a.m. May 14, 2014
- PR Newswire - PRF

Agreements, Earnings Releases, Senior-Level Retirements and Appointments, and Marketing Authorizations - Analyst Notes on Actavis, Jazz Pharmaceuticals, Bristol-Myers, Biogen Idec and AbbVie
7:00 a.m. May 14, 2014
- PR Newswire - PRF

Actavis Receives Final Approval for Generic Version of Exalgo®
5:00 p.m. May 13, 2014
- PR Newswire - PRF

Actavis to Present at Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference 2014
4:45 p.m. May 13, 2014
- PR Newswire - PRF

Actavis Announces Acanya® Gel Patent Challenge Settlement
8:00 a.m. May 12, 2014
- PR Newswire - PRF

Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
11:30 a.m. May 9, 2014
- PR Newswire - PRF

Actavis Launches Generic Version of Catapres-TTS®
4:05 p.m. May 7, 2014
- PR Newswire - PRF

Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie
9:00 a.m. May 6, 2014
- PR Newswire - PRF

Actavis and Forest Announce Effectiveness of Registration Statement
on Form S-4
9:02 a.m. May 5, 2014
- BusinessWire - BZX

Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
9:00 a.m. May 5, 2014
- PR Newswire - PRF

Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline
and Drop Tax Rate, an Industrial Info News Alert
6:31 a.m. April 30, 2014
- Marketwire

Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources
4:36 a.m. April 30, 2014
- PR Newswire - PRF

Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval
5:14 p.m. April 28, 2014
- PR Newswire - PRF

Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
8:00 a.m. April 28, 2014
- PR Newswire - PRF

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF

Actavis Announces Celebrex® Patent Challenge Settlement
9:20 a.m. April 24, 2014
- PR Newswire - PRF

Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D
9:03 a.m. April 21, 2014
- PR Newswire - PRF

Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF

Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Creality Rolls Out K3, SPARKX i8 at IFA 2026

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Morpho Unveils Versatile UV Printer at IFA 2026

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

See's Candies Data Breach Spurs Legal Scrutiny

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

York Space Systems Faces Class Action Over Misleading IPO

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

LiberNovo Demos Ergonomic Seating at IFA 2026

Riding the Ergonomic Wave at IFA 2026 No stranger to the innovation spotlight, LiberNovo’s got its eyes on Berlin this time around. As sparks fly at the IFA 2026, they’re rolling out their grand Maxis Series and rubbing shoulders with big names in technology. How does a company shake things up in a sea of tech? Start by thinking big and tall—literally. Maxis Series:...